Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$2.0B
Avg Funding
$78.9M
Global Reach
6
countries

Top Cities for Therapeutics

Miami
Berwyn
Boston
Cambridge
Laguna Hills
New York

Recently Funded Companies

Export
Miami, United States

Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.

$456K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Berwyn, United States

Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.

$1.6M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.

$15.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

$100.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Laguna Hills, United States

Sensible Care is a healthcare company that offers comprehensive care for mental illness in-clinic and online.

$2.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Grow Therapy offers online therapy services that connects individuals with licensed therapists to support mental health.

$150.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Tampa, United States

Sage Infusion is an infusion center for patients with autoimmune disorders and chronic infusion needs.

$11.8M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

$9.4M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.

$505.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

$3.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Aarhus, Denmark

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.

$1.5M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Chicago, United States

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

$30.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Haddonfield, United States

Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.

$5.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Dublin, United States

LainaHealth provides an AI-powered virtual platform for physical therapy, connecting therapists and patients for remote care management.

$5.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Wayne, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

$200.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

$60.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Raleigh, United States

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

$130.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

$150.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Alderley Park, United Kingdom

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

$8.1M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

$100.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

BrainStim Health operates mental health facilities that specialize in neuroplasticity-based treatments such as TMS and ketamine therapy.

$1.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

College Park, United States

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments

$75.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.

$2.4M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Axmed is a medical marketplace that offers access to medicines for healthcare providers through business and technology solutions.

$6.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

$400.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Showing 326 to 350 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$78.9M
Total Funding Tracked
$2.0B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
3 companies$350.0M
2.Boston
2 companies$18.3M
3.New York
2 companies$550.0M
4.Miami
1 companies$456K
5.Berwyn
1 companies$1.6M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked